Have your own idea? Try our Stock Screener
U.K. (FTSE) Life Sciences Industry Analysis
UpdatedJun 08, 2026
DataAggregated Company Financials
Companies7
- 7D-7.6%
- 3M9.1%
- 1Y6.2%
- YTD2.8%
Over the last 7 days, the Life Sciences industry has dropped 7.6%, driven by a pullback from Oxford Nanopore Technologies of 9.0%. On the other hand hVIVO is actually up 6.6%. In the past year, the industry has gained 6.4%. Earnings are forecast to grow by 56% annually.
Industry Valuation and Performance
Has the U.K. Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 08 Jun 2026 | UK£1.5b | UK£323.0m | -UK£166,018,254.00 | 1235.1x | -9x | 4.6x |
| Wed, 06 May 2026 | UK£1.3b | UK£318.2m | -UK£167,469,254.00 | n/a | -7.9x | 4.2x |
| Fri, 03 Apr 2026 | UK£1.4b | UK£323.0m | -UK£156,192,254.00 | 8.2x | -8.8x | 4.2x |
| Sun, 01 Mar 2026 | UK£1.5b | UK£304.7m | -UK£159,511,254.00 | 10.9x | -9.5x | 5x |
| Tue, 27 Jan 2026 | UK£1.9b | UK£304.6m | -UK£159,441,254.00 | 7.6x | -11.8x | 6.2x |
| Thu, 25 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.8x | -9x | 4.7x |
| Sat, 22 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 7.5x | -9.2x | 4.9x |
| Mon, 20 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 9.1x | -9.8x | 5.2x |
| Wed, 17 Sep 2025 | UK£1.7b | UK£313.5m | -UK£158,190,352.00 | 6x | -11x | 5.6x |
| Fri, 15 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -14.1x | 7.8x |
| Sun, 13 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -10.1x | 5.6x |
| Tue, 10 Jun 2025 | UK£1.6b | UK£319.4m | -UK£190,765,820.20 | 7.2x | -8.3x | 5x |
| Thu, 08 May 2025 | UK£1.6b | UK£313.9m | -UK£192,415,585.85 | 11.5x | -8.4x | 5.2x |
| Sat, 05 Apr 2025 | UK£1.4b | UK£315.9m | -UK£186,638,286.55 | 5.7x | -7.7x | 4.5x |
| Mon, 03 Mar 2025 | UK£1.6b | UK£306.6m | -UK£195,708,111.60 | 6.4x | -8.3x | 5.3x |
| Wed, 29 Jan 2025 | UK£2.0b | UK£307.0m | -UK£195,594,678.72 | 8x | -10.2x | 6.5x |
| Fri, 27 Dec 2024 | UK£1.9b | UK£306.7m | -UK£195,384,193.68 | 7.6x | -9.8x | 6.2x |
| Sun, 24 Nov 2024 | UK£1.8b | UK£306.7m | -UK£193,151,466.80 | 8.6x | -9.3x | 5.9x |
| Tue, 22 Oct 2024 | UK£2.0b | UK£304.6m | -UK£192,519,183.70 | 11x | -10.5x | 6.6x |
| Thu, 19 Sep 2024 | UK£2.2b | UK£304.2m | -UK£191,938,408.80 | 11.2x | -11.2x | 7.1x |
| Sat, 17 Aug 2024 | UK£1.9b | UK£296.2m | -UK£188,767,577.70 | 12.3x | -9.9x | 6.3x |
| Mon, 15 Jul 2024 | UK£1.6b | UK£295.1m | -UK£189,558,138.03 | 11.4x | -8.5x | 5.5x |
| Wed, 12 Jun 2024 | UK£1.6b | UK£295.6m | -UK£189,815,501.28 | 11.4x | -8.5x | 5.4x |
| Fri, 10 May 2024 | UK£1.7b | UK£295.1m | -UK£187,876,103.51 | 6867.6x | -9x | 5.7x |
| Sun, 07 Apr 2024 | UK£1.7b | UK£319.1m | -UK£191,365,932.27 | 69.8x | -8.7x | 5.2x |
| Tue, 05 Mar 2024 | UK£1.8b | UK£285.7m | -UK£189,163,354.53 | 6750.9x | -9.5x | 6.3x |
| Thu, 01 Feb 2024 | UK£2.9b | UK£450.3m | -UK£176,657,558.00 | 69.3x | -16.2x | 6.4x |
| Sat, 30 Dec 2023 | UK£3.2b | UK£449.9m | -UK£173,922,769.00 | 56.2x | -18.3x | 7.1x |
| Mon, 27 Nov 2023 | UK£3.0b | UK£455.4m | -UK£168,510,998.00 | 49.9x | -17.9x | 6.6x |
| Wed, 25 Oct 2023 | UK£3.1b | UK£458.5m | -UK£165,458,324.00 | 47.1x | -18.9x | 6.8x |
| Fri, 22 Sep 2023 | UK£3.1b | UK£440.9m | -UK£167,332,420.00 | 67.5x | -18.3x | 7x |
| Sun, 20 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,481,538.00 | 70.6x | -24.3x | 6.4x |
| Tue, 18 Jul 2023 | UK£3.3b | UK£475.7m | -UK£124,096,359.00 | 65.2x | -26.7x | 7x |
| Thu, 15 Jun 2023 | UK£3.1b | UK£476.6m | -UK£124,793,089.00 | 66.1x | -24.9x | 6.5x |
Price to Earnings Ratio
-24.9x
Current Industry PE
- Investors are pessimistic on the British Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.6x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -0.10% | |
| Healthcare | 3.44% | |
| Life Sciences | -7.65% | |
| Clinical Research and Equipment | -7.65% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HVO hVIVO | UK£0.088 | 7.3% +UK£4.1m | -21.3% | PS1.2x | |
| PRM Proteome Sciences | UK£0.016 | 13.5% +UK£666.4k | -52.1% | PS1.5x | |
| OBD Oxford BioDynamics | UK£0.0019 | 2.7% +UK£214.5k | -52.5% | PS7.4x |